Florence Retina Meeting
Florence (Italy)27-30 April 2017
FLOREtina 2017
Organizers:Stanislao Rizzo - Florence (Italy)
Carl Claes - Antwerpen (Belgium)José García-Arumí - Barcelona (Spain)
Kourous A. Rezaei - Chicago (USA)Ramin Tadayoni - Paris (France)
Albert Augustin - Karlsruhe (Germany)
FINAL PROGRAM
1
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
UNDER THE PATRONAGE OF:
DCMTDipartimento di Chirurgiae Medicina TraslazionaleDepartment of Surgery and Translational Medicine
CONTENT
WELCOME pag. 2
COMMITTEES & FACULTY pag. 3
PROGRAM OVERVIEW pag. 4
MAIN PROGRAM pag. 6 Thursday Institutional Symposia pag. 6
Friday Institutional Symposia - Morning pag. 8Friday Sponsored Lunch Symposia pag. 10Friday Institutional Symposia - Afternoon pag. 11
Saturday Institutional Symposia - Morning pag. 14Saturday Sponsored Lunch Symposia pag. 15Saturday Institutional Symposia - Afternoon pag. 17
Sunday Institutional Symposia pag. 19
COURSES pag. 21 Thursday Courses pag. 21Saturday Courses pag. 22
WET LABS pag. 23
ORAL PRESENTATIONS pag. 24 Thursday Presentations - Surgical Session 1 pag. 24Thursday Presentations - Medical Session 1 pag. 25Sunday Presentations - Surgical Session 2 pag. 26Sunday Presentations - Medica Session 2 pag. 27
POSTER PRESENTATIONS pag. 28Poster Presentations 1 - Medical Retina pag. 28Poster Presentations 2 - Surgical Retina pag. 30
GENERAL INFORMATION pag. 32
ACKNOWLEDGMENTS pag. 33
3
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
2
Dear Friends and Colleagues, We have the pleasure to invite you for the second edition of FLOREtina, from 27 to 30 April, 2017, in the beautiful city of Florence. Principal aim of the meeting that we are organizing, is to gather international active primary players in the retina field.ABiannualMeetingofferingthechancetosharestate-of-the-artonsurgicaltechniques,livesurgeryandinter-ventional medical treatments presented through pros&cons, debates and video sessions. TheFLOREtina2015“firstedition”exceededallexpectations:• More than 1000 delegates.• Active delegates’ participation with 80 papers and posters followed by discussion and interactive research debates withexpertsonSundaymorning.•The“LuigiBarca”awardsforresearchinophthalmology(bestposterandbestmedicalandsurgicaloralpresentations) have been assigned to promising young international ophthalmologists after independent evaluation by three organizers.•Successof theLiveSurgery that reached thehighestqualitystandardof thesessions’organizationand image transmission.•Boardsandusermeetingsforthecompanies. Medical retina sessions will target on updated treatment protocols in AMD, diabetic retinopathy and macular edema.Vascularandinflammatoryretinopathies,newimagingandavailabletreatmentoptionswillbemaintopics.Newmachines,instrumentsandsurgicaltechniqueswillbepresentedintwosessionsofvitreoretinallivesurgery. It is our intention to widen the meeting audience by creating an on-line educational streaming platform. Interactivity will be increased between speakers, moderators and participants through the App that allowed active involvement of the attendees. Looking forward to welcoming you to Florence, Stanislao Rizzo Carl Claes José García-ArumíKourous A. RezaeiRamin TadayoniAlbert Augustin
COMMITTEES AND FACULTY
ORGANIZERSStanislao Rizzo, ItalyCarl Claes, BelgiumJosé García-Arumí, SpainKourous A. Rezaei, USARamin Tadayoni, FranceAlbert Augustin, Germany .SCIENTIFIC PROGRAM CHAIRFrancesco Faraldi, Italy
SCIENTIFIC SECRETARIATAndrea Giorni, ItalyAlfonso Savastano, ItalyTomaso Caporossi, ItalyFrancesco Barca, Italy
FACULTYInternational Speakers Saba Al Rashaed, Saudi ArabiaFernando Arevalo, USARemzi Avci, TurkeyCarl C. Awh, USAErnesto Bali, BelgiumFrancine Behar Cohen, SwitzerlandSusanne Binder, AustriaPeriklis Brazitikos, GreeceSusan Bressler, USANeil Bressler, USAAlexander J. Brucker, USAAntonio Jr. Capone, USASteve Charles, USADavid Chow, CanadaGabriel Coscas, FranceEduardo Cunha de Souza, BrazilDonald J. D’Amico, USALyndon Da Cruz, UKMarc De Smet, SwitzerlandMarie-Noëlle Delyfer, FranceFrançois Devin, FranceKimberly Drenser, USAPravin U. Dugel, USAClaus Eckardt, GermanyUte Eckardt, GermanyEhab EL Rayes, EgyptPhilip Ferrone, USAMarta Figueroa, SpainThomas Friberg, USAHeinrich Gerding, Switzerland
André Gomes, BrazilStratos Gotzaridis, GreeceGiuseppe Guarnaccia, SwitzerlandSébastien Guigou, FranceTarek Hassan, USAHeinrich Heimann, UKAllen C. Ho, USASuber Huang, USAMark Humayun, USAKristel Jansen, BelgiumKazuaki Kadonosono, JapanBaruch Kuppermann, USABart P. Leroy, BelgiumAnat Loewenstein, IsraelRobert MacLaren, UKTamer Mahmoud, USAAndre Maia, BrazilCarlos Mateo, SpainJoseph Moisseiev, IsraelVirgilio Morales-Canton, MexicoMarco Mura, Saudi ArabiaJeroni Nadal, SpainManish Nagpal, IndiaS. Natarajan, IndiaAthanasios Nikolakopoulos, GreeceYuichiro Ogura, JapanMarta Oller Garcia, SpainYusuke Oshima, JapanKirk Packo, USAMichel Paques, FranceFahd Quhill, UKCarl D. Regillo, USAGisbert Richard, GermanyZena Rodrigues, UKKhalid Sabti, KuwaitGabor B. Scharioth, GermanyUrsula Schmidt-Erfurth, AustriaRicarda G. Schumann, GermanyStephen G. Schwartz, USASteven D. Schwartz, USAGaurav K. Shah, USAMalhar Soni, UKRick F. Spaide, USAPeter Stalmans, BelgiumPaulo Stanga, UKDavid Steel, UKHiroko Terasaki, JapanMichael Trese, USAPatricia Udaondo, Spain
Jan van Meurs, The NetherlandsThomas Wolfensberger, SwitzerlandDavid Wong, UKYoung-Hee Yoon, South CoreaMarco Zarbin, USAEberhart Zrenner, GermanySandrine Zweifel, Switzerland
National Speakers Chiara Adembri, ItalyMartina Angi, ItalyPaolo Arpa, ItalyTeresio Avitabile, ItalyClaudio Azzolini, ItalyDaniela Bacherini, ItalyGloria Badin, ItalyPaola Bagnoli, ItalyFrancesco Bandello, ItalyAnna Barducco, ItalyMaurizio Battaglia Parodi, ItalyGiorgio Beltrame, ItalyIlaria Biagini, ItalyFrancesco Boscia, ItalyFerdinando Bottoni, ItalyMichela Calandra, ItalyEmilio Campos, ItalyClaudio Carbonara, ItalyLuigi Caretti, ItalyPaolo Carpineto, ItalyMarzio Chizzolini, ItalyAntonio Ciardella, ItalyLuca Cimino, ItalyLaura Cinelli, ItalyMarco Coassin, ItalyMichele Coppola, ItalyStefano De Cillà, ItalyVito De Molfetta, ItalyDilva Drago, ItalyBruno Falcomatà, ItalyElena Febbrini Del Magro, ItalyFabrizio Franco, ItalyGiovanni Giacomelli, ItalyFabrizio Giansanti, ItalyAlfonso Giovannini, ItalyPaolo Lanzetta, ItalyGuido Lesnoni, ItalyMaurizio Licata, ItalyBruno Lumbroso, ItalyCesare Mariotti, Italy
Leonardo Mastopasqua, ItalyCinzia Mazzini, ItalyMichele Meglio, ItalyUgo Menchini, ItalyRita Mencucci, ItalyEdoardo Midena, ItalyAlba Miele, ItalyStefania Miotto, ItalyElisabetta Miserocchi, ItalySabrina Morroni, ItalyPiergiorgio Neri, ItalyMassimo Nicolò, ItalyClaudio Panico, ItalyGiorgio Panozzo, ItalyMarina Papadia, ItalyBarbara Parolini, ItalyMariacristina Parravano, ItalyFabio Patelli, ItalyAlfredo Pece, ItalyGrazia Pertile, ItalyGiulio Piana, ItalyStefano Piermarocchi, ItalyLuisa Pierro, ItalyElisabetta Pilotto, ItalyGiuseppe Querques, ItalyFederico Ricci, ItalyGuido Ripandelli, ItalyMario Romano, ItalyTommaso Rossi, ItalyMaria Cristina Savastano, ItalySandro Saviano, ItalyFrancesco Scaglione, ItalyVincenzo Scorcia, ItalyAndrea Scupola, ItalyFrancesca Simonelli, ItalyAndrea Sodi, ItalyGiovanni Staurenghi, ItalyMario Stirpe, ItalyDaniele Tognetto, ItalyGian Marco Tosi, ItalyLaura Turrisi, ItalyLorenzo Vannozzi, ItalyMonica Varano, ItalyMarco Vecchi, ItalyFrancesco Viola, ItalyGianni Virgili, ItalyGiovanni Zarlenga, ItalySilvio Zuccarini, Italy David Zucchini, Italy
5
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
4
PROGRAM OVERVIEW
AUDITORIUM (1000)
ROOM VERDE (190)
ROOM ONICE (75)
ROOM LIMONAIA (120)
ROOM 9 (40)
ROOM 6 (30)
ROOM 5 (30)
ROOM 4 (50)
Thur
sday
27
13:00 - 14:30 FREE PAPERS 1 SURGICAL RETINA 1
FREE PAPERS 2 MEDICAL RETINA 1
14:30 - 15:30 IMAGING
ALCONExperienceAcademy
NURSE COURSEBAUSCH & LOMB
Hypersonic Experience15:30 - 16:30 ESASO FORUM
DUKE COURSE: VITRE-ORETINAL SURGICAL
ROUNDS
BIOMETRY ADVANCED COURSE
ALLERGAN COURSE Real life in DME:
patients management with
clinical cases and debate
16:30 - 17:00 COFFEE BREAK
17:00 - 18:30 DIABETICRETINOPATHY
ALCONExperience Academy
BAUSCH & LOMB Hypersonic Experience
Frid
ay 28
08:00 - 09:30
3D LIVESURGERY
SURGICAL ROUND
RETINAL DYSTROPHIES
ALCONExperienceAcademy
BAUSCH & LOMB Hypersonic Experience
09:30 - 10:30INFLAMMATORY AND
INFECTIUS POSTERIOR UVEITIS
10:30 - 12:00 CHALLENGING CASES IN MACULAR DISEASES
12:00 - 13:10 3D VIDEO SESSION
13:10 - 14:10
LUNCH
ALCON SYMPOSIUMAdvancing
vitreoretinal surgery: 3D visualization
and beyond
ALLERGAN SYMPOSIUM
Recent advances in the management of patients
with DME
BAYERSYMPOSIUM Aflibercept:
efficacy matching efficiency
ALCONExperienceAcademy
SIFI SYMPOSIUM A persistent
treatment for apermanent disease
BAUSCH & LOMB Hypersonic Experience
ZEISS Hands OnAngioplex
Technology
GEUDERSYMPOSIUM
Clinical evaluationof next generation
vitreoretinal liquids
14:20 - 15:25 MACULAR SURGERY ALCONExperience Academy15:25 - 16:45 INNOVATION
16:45 - 17:15COFFEE BREAK
POSTERS 1 MEDICAL RETINA - POSTER AREA
17:15 - 17:30
ZIVOJNOVIC VITREORETINAL
FELLOSHIP PRESENTATION
MASTERS OF RETINAL DISEASES AWARDS ALCON
ExperienceAcademy
BAUSCH & LOMB Hypersonic Experience
17:30 - 17:40 PEDIATRIC RETINA LECTURE
17:40 - 18:10 PEDIATRIC RETINA PANEL
18:10 - 19:15 AMD
AUDITORIUM (1000)
ROOM VERDE (190)
ROOM ONICE (75)
ROOM LIMONAIA
(120)
ROOM 9 (40)
ROOM 6 (30)
ROOM 5 (30)
ROOM 4 (50)
ROOM 101 (50)
ADUA 1 (100)
ADUA 2 (120)
ADUA 3 (130)
Satu
rday
29
08:00 - 10:00 3D LIVESURGERY
SURGICAL
ROUND
ALCONExperienceAcademy
BAUSCH & LOMB Hypersonic Experience
10:00 - 12:00 AIORAO COURSE
12:00 - 13:00 RETINAWS
13:00 - 14:00
LUNCH
BAUSCH & LOMB SYMPOSIUM Advances in
ocular surgery and therapeutics
SECOND SIGHTSYMPOSIUM
Argus® II, enduring benefits,
expanding indications and
upgradesALCON
ExperienceAcademy
DORCSYMPOSIUM
Evolution into VR
Technologies: the new gold
standard BAUSCH & LOMB Hypersonic Experience
ZEISS Hands OnAngioplex
Technology
SOOFTSYMPOSIUM Retina and
inflammation
Appropriateness and
sustainability of the treatment of maculopathies
ALCON SYMPOSIUM Innovation
in combined surgery
ZEISSSYMPOSIUMIntraoperative
OCT: relevance in
daily practice
NIDEK SYMPOSIUM New Views
on the Retina with Multimodal
Imaging:Correlating Structure, Function
and Retinal Sensitivity
14:30 - 15:30 RETINALDETACHMENT
15:30 - 16:30ASRS SESSION:
VASCULAR RETINAL
DISEASES
16:30 - 17:00COFFEE BREAK
POSTERS 2 SURGICAL RETINA - POSTER AREA
17:00 - 18:15 MYOPIC MACULOPATHY
ALCONExperienceAcademy
BAUSCH & LOMB Hypersonic Experience18:15- 19:15
CHALLENGING CASES IN
MEDICAL AND SURGICAL
RETINA
Sund
ay 30
08:00 - 09:30FREE
PAPERS 3 SURGICAL RETINA 2
FREE PAPERS 4 MEDICAL RETINA 2 ALCON
ExperienceAcademy
BAUSCH & LOMB Hypersonic Experience09:30 - 10:30
VITREO-RETINAL SURGERY: THE
A-B-C
10:30 - 10:40 LECTURE
10:40 - 11:00 COFFEE BREAK
11:00 - 12:00 MISTERY CASES
ALCONExperienceAcademy
BAUSCH & LOMB Hypersonic Experience
12:00 - 13:00VITREO-RETINAL
SURGERY ADVANCED
COURSE
13:00 - 13:15 FREE PAPER BARCA AWARDS
ROOM(seats)
Day/Time
ROOM(seats)
Day/Time
7
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
6
THURSDAY 27 April 2017
THURSDAY 27 April 2017 THURSDAY 27 April 2017
MAIN SESSION (13:00-16:30)
13:00-14:30 FREE PAPERS 1 - SURGICAL RETINA 1ROOM VERDE Chairs: P. Stanga, J. Moisseiev Moderators: T. Friberg, S.D. Schwartz
13:00-14:30 FREE PAPERS 2 - MEDICAL RETINA 1ROOM ONICE Chairs: S. Bressler, M. ZarbinModerators: A. Loewenstein, U. Schmidt-Erfurth
14:30-15:30 ANGIO-OCT in MULTIMODAL IMAGINGROOM VERDE Chairs: G. Coscas, B. Lumbroso, L. Mastropasqua14:30 - OCT Angiography technologies. Differences and similarities between instruments. G. Staurenghi14:35 - Sensitivity, specificity and limitations of Optical Coherence Tomography Angiography in diagnosis of CNV. M.C. Savastano14:40 - Long term patterns of CNV treatment response and aspects of CNV recurrences. B. Lumbroso14:45 - OCT A and individual retinal layers in pre-clinical diabetic retinopathy. E. Midena14:50 - Discussion
15:00 - OCT A in dry AMD. G. Querques15:05 - OCT Angiography changes in vitreo-macular interface surgery. L. Mastropasqua15:10 - Panoramic views of OCT angio. M. Nagpal15:15 - Vascular abnormalities in vitreomacular interface diseases: novel data from OCT Angiography. L.Pierro15:20 - Discussion
15:30-16:30 ESASO FORUMCSC Behind the Appearances
ROOM VERDEChairs: F. Bandello, G. Guarnaccia, M. ZarbinScientific Project: B. Falcomatà15:30 - Theories of pathogenesis and correlation with other diseases. R. Spaide15:37 - Clinical manifestations, masquerading syndrome. S. Zweifel
15:44 - Mechanisms of action of treatments. M. Zarbin15:51 - Indications and efficacy of treatments options. M. Battaglia Parodi15:58 - Long standing and complicated CSC. G. Staurenghi16:05 - Cases study of CSC Management. A. Loewenstein16:12 - Discussion
15:30-16:30 DUKE COURSE: VITREORETINAL SURGICAL ROUNDSMacular Surgery. Tips, Tricks and Innovations
ROOM ONICE Chair: T. MahmoudPanelists: C. Awh, D.J. D’Amico, K. Drenser, P. Dugel, P. Ferrone, M. Figueroa, B. Parolini
16:30-17:00 COFFEE BREAK
MAIN SESSION (17:00-18:30)
17:00-18:30 DIABETIC RETINOPATHYAUDITORIUM Chairs: N. Bressler, S. Bressler17:00 - Epidemiology of diabetic retinopathy: magnitude of the problem. E. Midena17:06 - Which Anti-VEGF agent for DME. A. Loewenstein17:12 - Comparison of Anti-VEGF to laser or corticosteroids for DME. R. Tadayoni17:18 - Rationale for treatment algorithm for DME. S. Bressler17:24 - Discussion
17:34 - Effect of cataract surgery on DME. S. Zweifel17:40 - PRP vs. Anti-VEGF for proliferative diabetic retinopathy with DME. N. Bressler17:46 - What else? Management of non-central DME or central DME with very good vision. F. Bandello17:52 - Ongoing RCT and upcoming treatments. M. Zarbin17:58 - Discussion and case presentation on treatment choice and protocols. N. Bressler, S. Bressler
9
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
8
FRIDAY 28 April 2017
FRIDAY 28 April 2017 FRIDAY 28 April 2017
09:30-10:30 INFLAMMATORY AND INFECTIOUS POSTERIOR UVEITIS: Misdiagnosis & therapeutic mistakes ROOM VERDE Chairs: T. Friberg, E. Midena, A. Ciardella09:30 - Toxoplasmic chorioretinitis still underdiagnosed. L. Vannozzi09:36 - Ocular syphilis: the return of an old acquaintance. P. Neri09:42 - Ocular tuberculosis. No more borders. L. Cimino09:48 - Intraocular lymphoma, the king of masquerades syndromes. M. Angi09:54 - Multimodal imaging in the diagnosis of choriocapillaritis. M. Papadia10:00 - Promptly diagnose and treat viral retinitis. E. Miserocchi10:06 - Discussion
10:30-12:00 CHALLENGING CASES IN MACULAR DISEASESROOM VERDE Chairs: G. Querques, R. Spaide, F. Bottoni10:30 - Perifoveal Vascular Abnormal Complex (PEVAC). G. Querques10:36 - Spectrum of the diseases of capillary retinal plexi. F. Viola10:42 - The occult aspects of the macula. S. Piermarocchi10:48 - Subretinal hypereflective material. M. Parravano10:54 - Maculopathy resolution after surgery for optic disc pit: a long-term follow-up study. F. Bottoni11:00 - Discussion
11:10 - Extensive macular atrophy with pseudodrusen in non-aged subjects. E. Pilotto11:16 - Early onset drusen: stars in the sky, honeycomb and donut in young subjects. A. Giovannini11:22 - The dome in the macula. M. Varano11:28 - CNV in CSC. M. Nicolò11:34 - Improving the age-related macular degeneration construct: a new classification system. R. Spaide11:43 - Relevant clinical trials. P. Dugel11:49 - Discussion
12:00-13:10 3D VIDEO SESSIONAUDITORIUM Chair: E. EL Rayes12:00 - The reason why I switched to 3D surgery. S. Charles12:06 - Digitally assisted vitrectomy systems. K. Packo12:12 - PANELPanelists: C. Eckardt, T. Hassan, J. García-Arumí , C. Mariotti, Y. Oshima, G. Pertile , R. Tadayoni
MAIN SESSION (08:00-13:10)
08:00-12:00 3D LIVE SURGERYAUDITORIUM Moderators in the O.R.: D.J. D’Amico, D.Wong Moderators in the Auditorium: F. Patelli, D. Steel Panelists: T. Avitabile, C. Azzolini, P. Carpineto, L. Da Cruz, C. Panico
SURGICAL ROUND (5 mins/each)- Scleral buckling with chandelier illumination in 3D. C. Panico- New evidences for the intraoperative prevention of PVR. C. Azzolini- OCT prognostic signs in vitreo-macular interface pathologies. P. Carpineto- The role of Biopsy in the diagnosis and management of retinal diseases. L. Da Cruz- Delayed suprachoroidal hemorrhage after pars plana vitrectomy. T. Avitabile
08:30-09:30 RETINAL DYSTROPHIES: Update on diagnosis and treatmentROOM VERDE Chairs: S.D. Schwartz, B. Leroy, F. SimonelliModerator: A. Sodi08:30 - Retinal dystrophies: an update. B. Leroy08:35 - Adaptive optics in retinal dystrophies. M. Paques08:40 - OCT Angiography in retinal dystrophies. D. Bacherini08:45 - Gene therapy for retinal dystrophies - potential and pitfalls. S. Huang08:50 - Discussion
09:00 - Gene therapy for choroideremia. R. MacLaren09:05 - Stem cells for retinal dystrophies. S.D. Schwartz09:10 - The new electronic subretinal implant alpha AMS: results in 15 patients blind from hereditary retinal degeneration. E. Zrenner09:15 - Argus II: current developments and future perspectives. S. Huang09:20 - Discussion
11
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
10 FRIDAY 28 April 2017 FRIDAY 28 April 2017
13:10-14:30 LUNCH & SPONSORED LUNCH SYMPOSIA
13:10-14:10 ALCON SYMPOSIUMAdvancing vitreoretinal surgery: 3D visualization and beyond
AUDITORIUM 13:10 - Advancing from optical microscopy to 3D visualization 13:22 - Enhancing surgeons view in vitreoretinal surgery13:34 - Introducing the bevel tip into vitrectomy probes13:46 - Optimizing small gauge vitreoretinal surgery13:58 - Discussion
13:10-14:10 ALLERGAN SYMPOSIUMRecent advances in the management of patients with DME
ROOM VERDE Chairs: F. Bandello, A. Loewenstein13:10 - Inflammation in DME. F. Behar Cohen13:20 - OCT angiography in clinical practice. G. Staurenghi13:30 - Biomarkers in DME. M. de Smet 13:40 - DME patient management in first line. B. Kupperman13:50 - Clinical cases. G. Panozzo, P. Udaondo, A. Loewenstein14:00 - Discussion
13:10-14:10 BAYER SYMPOSIUMAflibercept: efficacy matching efficiency
ROOM ONICE Moderators: F. Faraldi, E. Midena13:10 - DME: correlation between treatment regimen and outcomes. S. Saviano13:22 - Aflibercept: effective and efficient scheduling. F. Ricci13:34 - Ask the expert. F. Faraldi13:46 - Take home messages. E. Midena13:58 - Discussion
13:10-14:10 SIFI SYMPOSIUMA persistent treatment for a permanent disease
ROOM 9 Moderator: E. Midena13:10 - Pathogenesis and clinical patterns of DME. E. Midena 13:25 - Pearls and pitfalls of the treatment P. Lanzetta 13:40 - Breaking news in the management of DME F. Quhill 13:55 - Discussion
13:10-14:10 GEUDER SYMPOSIUMClinical evaluation of next generation vitreoretinal liquids
ROOM 4 Chair: D. Wong13:10 - First experiences with colored PFCLs. T. Caporossi13:22 - Clinical evaluation of a heavier-than-water dual Bromphenol/Brilliant Blue dye. H. Gerding13:34 - The silicone interactions: the key of biocompatibility. M. Romano13:46 - Optimizing heavy silicone oils. D. Wong13:58 - Discussion
MAIN SESSION (14:20-16:45)
14:20-15:25 MACULAR SURGERYAUDITORIUM Chairs: R. Tadayoni, R. Spaide, E. Campos, K. Packo14:20 - Modern imaging of the vitreoretinal interface. R. Tadayoni14:25 - Macular combined surgery phacovitrectomy (including femtophaco). G. Richard14:30 - Best treatment for VMT: ocriplasmin, pneumatic vitreolysis or vitrectomy. P. Stalmans14:35 - Lamellar macular hole: updated classification and surgical indications. R.G. Schumann “Luigi Barca” Award 2015 winner
14:40 - Discussion
14:50 - New lens for macular diseases. G.B. Shariot14:55 - Retinal re-structuring on OCT following inverted flap surgery for large macular holes. H. Heimann15:00 - The role of the Müller cells in the macular surgery. M. Romano15:05 - Spontaneous ILM avulsions - possible precursor to epiretinal membrane formation. K. Packo15:10 - Binocular function and recovery following successful macular surgery. E. Campos15:15 - Discussion
13
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
12 FRIDAY 28 April 2017 FRIDAY 28 April 2017
15:25-16:45 INNOVATIONAUDITORIUM Chairs: S. Charles, M. Humayun, M. de Smet, C. Eckardt
Machines and instruments 15:30 - Abiotic-Biotic interfaces for ophtalmology. M. Humayun15:35 - Innovative PPVX system: ultrasonic vitrectomy. P. Stanga15:40 - Robotic vitrectomy: clinical applications and initial results. M. de Smet15:45 - New instruments in vitreoretinal surgery. D. Chow15:50 - 3D IOCT - Does it improve our surgical performance? S. Binder15:55 - Technical innovations in countries facing economic crisis. S. Gotzaridis16:00 - Artificial Intelligence and Retinal Image Analysis. S.D. Schwartz16:05 - Discussion
Submacular surgery 16:15 - Update on cellular transplantation for retinal disease. L. Da Cruz16:20 - Gene therapy for Leber Congenital Amaurosis. F. Simonelli16:25 - Gene therapy for retinal degenerations. R. MacLaren16:30 - Toward more precise subretinal therapeutic delivery: new techniques and instrumentation. A.C. Ho16:35 - Discussion
16:45-17:15 COFFEE BREAK & POSTERS 1 - MEDICAL RETINA
MAIN SESSION (17:15-19:15)
17:15-17:25 ZIVOJNOVICH VITREORETINAL FELLOWSHIP PRESENTATIONAUDITORIUM
17:25-17:30 MASTERS OF RETINAL DISEASES AWARDSAUDITORIUM
17:30-17:40 PEDIATRIC RETINA LECTUREAUDITORIUM - Pediatric retinal degenerations and retinal detachment: how do we treat? M. Trese
17:40-18:10 PEDIATRIC RETINA PANEL - What every retina specialist should know on pediatric casesAUDITORIUM Panelists: M. Trese, F. Barca, K. Drenser, E. EL Rayes, C. Claes, M. Mura, P. Ferrone Case Presentation: A. Capone
18:10-19:15 AMDAUDITORIUM Chairs: U. Schmidt-Erfurth, C. Awh, P. Dugel18:10 - Is there a genetic basis for AMD treatment? C. Awh18:16 - Dry AMD treatment, hopeful or hopeless? G. Staurenghi18:22 - What is the best treatment regimen? C. Regillo18:28 - How do we manage submacular hemorrhage? J. van Meurs18:34 - New treatment strategies for PCV. Y.H. Yoon18:40 - Big data imaging analysis: the next revolution. U. Schmidt-Erfurth18:46 - The Fovista (anti-PDGF) Phase 3 Trial: Results and Analysis. P. Dugel18:52 - Case presentation and panel discussion. P. Dugel
15
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
14 SATURDAY 29 April 2017 SATURDAY 29 April 2017
13:00-14:30 LUNCH & SPONSORED LUNCH SYMPOSIA
13:00-14:00 BAUSCH & LOMB SYMPOSIUMAdvances in ocular surgery and therapeutics
ROOM VERDE Chair: F. Boscia, R. Mencucci13:00 - Continuing Vitreoretinal surgery Innovation. C. Awh13:12 - Direct transretinal removal of subfoveal perfluorocarbon liquid: the role and timing of internal limiting membrane peeling. S. De Cillà13:24 - Ocular surface after posterior segment surgery. R. Mencucci13:36 - Bromfenac in management of Inflammatory conditions of posterior segment. P. Neri13:48 - Discussion
13:00-14:00 SECOND SIGHT SYMPOSIUMArgus® II, enduring benefits, expanding indications and upgrades
ROOM ONICE Chairs: M-N. Delyfer, A. Augustin, P. Stanga13:00 - Creating central vision function in AMD with the Argus II implant. P. Stanga 13:08 - Blind Bardet-Biedl syndrome patient treated with the Argus II Retinal Prosthesis System. A. Augustin13:16 - Surgical complications management in Argus II implantation procedures. M. Chizzolini13:24 - Interim results of Argus II clinical study in France. M-N. Delyfer13:32 - 30 Argus II cases under the belt? What’s next? L. Cinelli13:40 - Argus II implant. Lessons to learn. KKESH experience. S. Al Rashaed13:48 - Discussion
13:00-14:00 DORC SYMPOSIUM
ROOM 9 Chair: D. Tognetto13:00 - The light bulb moment: new insights into the application of LED blended light for VR surgery. D. Chow13:10 - Debunking the 27g hype: do the benefits of 27g truly outweigh the limitations? G.K. Shah13:20 - EVA Fluidics: improved understanding of fluidics options in surgical systems. M. Romano13:30 - A new phaco approach into combined cases. M. Vecchi13:40 - PFCL Purity: are we compromising patient safety with the push for lower cost VR liquids? M. Coassin13:50 - Discussion
MAIN SESSION (08:00-13:00)
08:00-12:00 3D LIVE SURGERYAUDITORIUM Moderators in the O.R.: D.J. D’Amico, D. WongModerators in the Auditorium: F. Patelli, D. SteelPanelists: F. Arevalo, C. Eckardt, C. Mariotti, T. Rossi
SURGICAL ROUND (5 mins/each)- Ocular perfusion control during vitrectomy increases vitrectomy safety. T. Rossi- My way of dye and PFCL injection in macular diseases and retinal detachment. C. Eckardt- TSV with tissue plasminogen activator, C3F8 and subretinal Anti-VEGF. C. Mariotti- Endogenous endophthalmitis in the developing world. F. Arevalo
12:00-13:00 RETINAWSAUDITORIUM Chair: K. RezaeiPanelists: R. Avci, S. Binder, F. Boscia, A. Ciardella, A. Gomes, C. Mateo, Y. Ogura, K. Packo, D. Steel, H. Terasaki
SATURDAY 29 April 2017
17
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
16 SATURDAY 29 April 2017 SATURDAY 29 April 2017
13:00-14:00 OO GROUP SYMPOSIUMRetina and inflammation
ROOM 4 Chair: F. Bandello13:00 - The inflammatory and immunological component in retinal diseases. G. Querques 13:10 - AMD and neuro-inflammation. S. Miotto 13:20 - Effect of a mixture of fatty acids in a murine model of MD. P. Bagnoli 13:30 - Use of intravitreal triamcinolone acetonide for macular edema: our experience with an on-label drug. A. Ciardella13:40 - Triamcinolone preservative-free as non-responder ocular inflammations therapy. P. Neri 13:50 - Discussion
13:00-14:00 ALCON SYMPOSIUMInnovation in combined surgery
ROOM ADUA 1 13:00 - Introduction and Interactive session “Questionnaire 1st wave“ M. Romano, C. Mariotti 13:10 - Innovation and advantages with Femtosecond laser assisted Cataract surgery in a combined procedure and therapeutical approach: Which implications? F. Barca, F. Scaglione 13:20 - Focus on ocular surface system in cornea surgery. V. Scorcia, F. Scaglione13:30 - Which are the crucial points in a combined procedures to obtain the best outcomes? M. Romano 13:50 - Interactive session “Questionnaire 2nd wave” and conclusions. M. Romano, C. Mariotti
13:00-14:00 ZEISS SYMPOSIUMIntraoperative OCT: relevance in daily practice
ROOM ADUA 2
13:00-14:00 Appropriateness and sustainability of the treatment of maculopathiesROOM 10113:00 - 10 years of AntiVEGF: what problems are still to be solved? F. Bandello13:15 - 10 years of antiVEGF: evolution of appropriateness and of sustainability in real life of treatment in Italy. F. Boscia13:30 - AntiVEGF: Switch or not switch. G. Staurenghi13:45 - Discussion
13:00-14:00 NIDEK SYMPOSIUMNew views on the retina with multimodal imaging: correlating structure, function and retinal sensitivity
ROOM ADUA 3 Moderator: S.D. Schwartz13:00 - Beyond the Structure: OCT Angiography and microperimetry in vitreoretinal interface disorders. D. Bacherini13:15 - OCT Angiography: our experience. M. Nagpal13:30 - Clinical utility of the OCT and retinal blood flow. S.D. Schwartz13:45 - Discussion
MAIN SESSION (14:30-16:30) 14:30-15:30 RETINAL DETACHMENT
AUDITORIUM Chairs: J. Garcia-Arumì, T. Avitabile, C. Mariotti14:30 - Vitrectomy for RRD comparing cases with PFCL to those without PFCL. J. Moisseiev14:35 - Small-Gauge PPV with gas for the repair of primary RRD with multiple and inferior breaks. F. Faraldi14:40 - Factors influencing retinal displacement after pars plana vitrectomy for repair of RRD. A. Scupola14:45 - When and how to perform retinotomy in retinal detachment surgery. J. Garcia-Arumì14:50 - Discussion15:00 - Posterior uveitis-associated rhegmatogenous retinal detachment. P. Brazitikos15:05 - 27G+ and silicone oil in complicated traumatic retinal detachment. A. Nikolakopoulos15:10 - Occurrence and treatment of diplopia after vitreoretinal surgery. U. Eckardt15:15 - Retinal detachment due to paravascular or juxtapapillary retinal breaks over patchy chorioretinal atrophy. T. Caporossi15:20 - Discussion
15:30-16:30 ASRS SESSION: VASCULAR RETINAL DISEASEAUDITORIUM Chairs: G. Shah, T. Hassan15:30 - OCT A of retinal vascular diseases. S.G. Schwartz15:37 - The role of inflammation in retinal vascular diseases. B. Kuppermann15:44 - Long term effects of Anti-VEGF therapy on retinovascular diseases. C. Regillo15:51 - Is ischemia in retinal vascular diseases reversible? T. Friberg15:58 - New findings in MacTel2 as determined by multimodal imaging including volume rendered optical coherence tomography angiography. R. Spaide16:05 - Vitrectomy for DME: why, how, and when. G. Shah16:12 - Discussion
19
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
18 SATURDAY 29 April 2017 SUNDAY 30 April 2017
MAIN SESSION (08:00-10:40)
08:00-09:30 FREE PAPERS 3 - SURGICAL RETINA 2ROOM VERDE Chairs: F. Devin, V. Morales Canton, G. RipandelliModerators: C. Mariotti, S. Binder
08:00-09:30 FREE PAPERS 4 - MEDICAL RETINA 2ROOM ONICE Chairs: U. Menchini, G. VirgiliModerators: F. Faraldi, S. Zweifel
09:30-10:30 VITREO-RETINAL SURGERY: THE A-B-CROOM VERDE Chairs: V. De Molfetta, D. Wong, C. AzzoliniModerators: D. Tognetto, G.M. Tosi, L. Caretti09:30 - Ab-interno and Ab-externo surgery: what choice?. D. Tognetto09:35 - Pneumatic retinopexy. M. Soni09:40 - Chromovitrectomy and type of dyes: virtuosity or necessity?. K. Kadonosono09:45 - Endophthalmitis management. F. Giansanti09:50 - Discussion
10:00 - Proliferative diabetic retinopathy: what to know before starting?. T. Caporossi10:05 - High myopia vitrectomy difficulties: how to approach?. M. Coppola10:10 - Surgical and pharmacological strategies for the prevention of the PVR. A. Savastano10:15 - Discussion
10:30-10:40 LECTURE ROOM VERDE - Type of endotamponades and their use and how to obtain a perfect filling. D. Wong
16:30-17:00 COFFEE BREAK & POSTERS 2 - SURGICAL RETINA
MAIN SESSION (17:00-19:15)
17:00-18:15 MYOPIC MACULOPATHYAUDITORIUM Chairs: A. Augustin, A. Brucker, M. Stirpe17:00 - Role of OCT angiography in multimodal imaging of myopic CNV. A. Pece17:05 - Myopic CNV: Anti-VEGF treatment long term results. P. Lanzetta17:10 - Dome shaped macula. F. Boscia17:15 - Myopic schisis and high myopia surgery: when is the right time to intervene. T. Wolfensberger17:20 - Vitreous floaters: is it time to change approach? Laser or surgery? A. Brucker17:25 - Discussion
Myopic macular hole surgical techniques: televoting17:35 - Autologous platelet rich plasma for the treatment of myopic macular holes. M. Figueroa17:40 - Inverted flap for myopic macular holes. M. Mura17:15 - Macular buckling as a first line treatment for myopic macular holes. C. Mateo17:50 - Internal limiting membrane graft for persistent myopic macular holes after primary surgical failure. J. Nadal17:55 - Autologous retina transplant for the treatment of myopic holes. T. Mahmoud18:00 - Discussion
18:15-19:15 CHALLENGING CASES IN MEDICAL AND SURGICAL RETINAAUDITORIUM Chairs: C. Claes, E. Cunha de SouzaPanelists: A. Lowenstein, D. Chow, G. Staurenghi, A. Brucker, B. Kuppermann
SUNDAY 30 April 2017
21
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
20 SUNDAY 30 April 2017
10:40-11:00 COFFEE BREAK
MAIN SESSION (11:00-13:15)
11:00-12:00 MISTERY CASESROOM VERDE Moderators: F. Boscia, R. TadayoniPanelists: G. Pertile, M. Figueroa, A. Capone, P. Stanga, E. EL Rayes, V. Morales Canton, C. Azzolini, M. Nagpal, T. Rossi, A. Kumar
12:00-13:00 VITREO-RETINAL SURGERY - ADVANCED COURSEROOM VERDE Chairs: G. Lesnoni, K. KadonosonoModerators: G. Beltrame, P. Arpa, T. Rossi12:00 - Unresolved issues in anesthesia for ophthalmic surgery. C. Adembri12:05 - Vitreo-retinal surgery in pediatric age: the differences from the adult surgery. F. Barca12:10 - Appropriate machine settings in different pathologic conditions. D. Steel12:15 - Combining scleral buckle and vitrectomy: when? J. Garcia-Arumì12:20 - Discussion
12:30 - Macular buckle. B. Parolini12:35 - Choroidal patch in AMD patients: when recommend to the patient? G. Pertile12:40 - Recurrence of PVR under silicon oil. D. Wong12:45 - Vitreous surgery for pellet ocular trauma. S. Natarajan12:50 - Discussion
13:00-13:15 FREE PAPER “LUIGI BARCA” AWARDROOM VERDE
COURSES
14:30-16:30 NURSE COURSE - Nurse’s role in the ophthalmic surgery: European experiences comparedROOM 9 Scientific Coordinators: L. Turrisi, D. Zucchini14:30 - ROUND TABLE S. Morroni, G. Zarlenga, K. Jansen, M. Oller Garcia, Z. Rodrigues15:30 - Driving innovation, efficiency and quality in the O.R. J. Burckhardt15:40 - Innovation in ophthalmic surgery: enhance the O.R. with the advancing technology. S. Fittipaldi15:50 - Future innovation in vitreoretinal surgery: Hypersonic vitrectomy. M. Bastier16:00 - Discussion
15:30-16:30 - BIOMETRY ADVANCED COURSEROOM 5 Scientific Coordinator: C. Mazzini 15:30 - Welcome and program overview. C. Mazzini15:35 - Biometry instruments: what’s new? C. Carbonara15:40 - Integrated acquisition system. F. Franco15:45 - When an optical biometry is not possible. C. Mazzini 15:50 - Discussion
Biometry in complex cases:16:00 - Corneal surgery. C. Mazzini16:05 - Vitrectomy. A. Miele 16:10 - Post refractive surgery. C. Carbonara16:15 - Discussion
15:30-16:30 ALLERGAN COURSEReal life in DME: patients management with clinical cases and debate
ROOM 4 Chairs: E. Midena, A. Loewenstein 15:30 - The inflammation in DME: rational behind. E. Midena15:40 - DME clinical cases. E. Pilotto, P. Udaondo, C. Parravano16:10 - Debate: Dex implant or Anti-VEGFs in naïve patients? F. Bandello, F. Ricci 16:20 - Discussion
THURSDAY 27 April 2017
23
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
22
COURSES WET LABS
10:00-12:00 AIORAO COURSE - The role of the Orthoptist in retinal disease management.ROOM ONICE Chair: E. CamposModerators: G. Virgili, D. Drago
Session I - Strabismus secondary to scleral buckling surgery10:00 - Lecture Strabismus after retinal detachment surgery: pathogenesis, clinical patterns, treatment timing and strategies. E. Campos 10:15 - Orthoptic evaluation of secondary strabismus. A. Barducco 10:22 - Diplopia: prisms management. M. Meglio 10:29 - Discussion
Session II - Clinical Trials10:39 - Fundamentals of Clinical Trials. G. Virgili 10:46 - Visual acuity certification (Standard ETDRS testing: refraction and BCVA). G. Piana 10:53 - Instruments certification (SD-OCT and fluorescein angiography). I. Biagini 11:00 - The role of Data Manager. G. Badin11:07 - Discussion
Session III - Low Vision11:17 - Retinal diseases and conditions causing vision loss. G. Giacomelli 11:24 - Low vision aids and magnification devices. E. Febbrini Del Magro 11:31 - The role of microperimetry in visual rehabilitation. M. Licata 11:38 - Clinical cases. M. Calandra 11:45 - Discussion
ALCON EXPERIENCE ACADEMY
ROOM LIMONAIA - Thursday 27 April 14:30-19:00 - Friday 28 April 08:00-18:30- Saturday 29 April 08:00-19:00- Sunday 30 April 08:00-13:00
BAUSCH & LOMB HYPERSONIC EXPERIENCE
ROOM 5 - Thursday 27 April 14:30-19:00 - Friday 28 April 08:00-18:30- Saturday 29 April 08:00-19:00- Sunday 30 April 08:00-13:00
SATURDAY 29 April 2017 The Wet Labs will be available all day for the duration of the conference as per specified times
ZEISS HANDS ON ANGIOPLEX TECHNOLOGY
ROOM 6 - Friday 28 April 13:10-14:10 - 13:10 OCT Angiography: advanced diagnosis in your daily work. P. Dugel - 13:40 Hands-on Session- Saturday 29 April 13:00-14:00 - 13:00 Hands-on Session - 13:25 OCT Angiography: advanced diagnosis in your daily work. G. Querques
25
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
24
ORAL PRESENTATIONS - SURGICAL SESSION 127 April, 13:00-14:30 - ROOM VERDE 3 minutes/each + 1 minute discussion
OS1-01 SURGICALLYEXCISEDEPIRETINALMEMBRANESINCELLCULTURED. Compera, C. Wertheimer, K.h. Eibl-Lindner, F. Vielmuth, V. Spindler, S. Priglinger, R.g. Schumann
OS1-02 FUNCTIONALANDANATOMICALOUTCOMESOFIDIOPATHICEPIRETINALMEMBRANEREMOVALACCORDINGTOTHEM.IL.A.N. (MACHINE-ILLUMINATION-ACCESSORIES-NOCONTACT)APPROACH
M. Coppola, M.V. Cicinelli, G. Querques, F. Bandello OS1-03 RETINALVASCULARCHANGESAFTERVITRECTOMYFORIDIOPATHICEPIRETINALMEMBRANE:APILOTSTUDYWITHDYNAMICVESSEL ANALYSIS
G. Fogliato, L. Iuliano, G. Querques, M. Codenotti, F. BandelloOS1-04 QUALITATIVEANDQUANTITATIVEASSESSMENTOFRETINALVASCULARIMPAIRMENTDUETOEPIRETINALMEMBRANE: OCT-ANGIOGRAPHY ANALYSIS
T. Fiore, M. Lupidi, E. Spaccini, C. Cagini, G. Coscas OS1-05 IDIOPATHICEPIRETINALMEMBRANE:ANEWTOOLFORTHEEVALUATIONOFMETAMORPHOPSIA
M. Dal Vecchio, F. Tripoli, C. Lavia, M. Nassisi, E. Buschini OS1-06 TROUMATICLARGEFULLTHICKNESSMACULARHOLE(SURGICALCASEPRESENTATION)
M. Tawfik, S. DabourOS1-07 AUTOLOGOUSINTERNALLIMITINGMEMBRANETRANSPLANTATIONFORREFRACTORYMACULARHOLE:AMODIFIEDSURGICAL TECHNIQUE
U. Lorenzi, P. Ramtohul, C. Marc, U. Lorenzi OS1-08 HISTOPATHOLOGY OF THE ILM FLAP AND ITS POTENTIAL OF NEURONAL REMODELING IN FULL-THICKNESS MACULAR HOLES
L. Mautone, C. Haritoglou, D. Compera, A. Wolf, S.g. Priglinger, R.g. Schumann OS1-09 BESTVITELLIFORMDYSTROPHYCOMPLICATEDBYMACULARHOLEASSOCIATEDRETINALDETACHMENTTREATEDWITHINVERTEDILM FLAP AND GAS TAMPONADE.
R. Tewari, V. Kumar, P. Chandra, A. Kumar OS1-10 COMPARISONOFINVERTEDFLAPANDSUBRETINALASPIRATIONTECHNIQUEINFULLTHICKNESSMACULARHOLESURGERY
E. Peiretti, C. Iovino, G. Caminiti, F. Nasini, G. Casini OS1-11 ROLE OF LAMELLAR HOLE-ASSOCIATED EPIRETINAL PROLIFERATION IN LAMELLAR MACULAR HOLES
R. Dell’omo, G. Virgili, S. Rizzo, S. De Turris, G. Coclite, D. Giorgio, E. Dell’omo, C. Costagliola OS1-12 FULLTHICKNESSMACULARHOLE:ANALTERNATIVETOTHE“INVERTEDFLAP”
S.S. Violanti, A. Imburgia, P. Tassinari, P. Perri OS1-13 ACTIVECLOSUREOFMACULARHOLEUSINGASPECIALLYDESIGNEDNEEDLE(VIDEO)
F. Balta OS1-14 INVERTEDINTERNALLIMITINGMEMBRANEFLAPFORLARGEMACULARHOLES
R. Giannini, T. Mascaro, L. Zompatori OS1-15 SUCCESSFULCLOSUREOFALARGEMACULARHOLEUSINGTHEINVERTEDINTERNALLIMITINGMEMBRANE(ILM)FLAPTECHNIQUE.
A. De Casas Fernández, S. Abenza Baeza, J.M. Marin Sanchez, J. Javaloy, J.C. Elvira OS1-16 VITRECTOMYWITHINTERNALLIMITINGMEMBRANEPEELINGANDINVERTEDFLAPTECHNIQUEFORA1,600MICROMETRESGIANT MACULAR HOLE
I. Roberts, E. Zarzosa, R. Hernandez, R. Portilla, E. Perez-Salvador OS1-17 HEIGHTANDGAPOFELM(EXTERNALLIMITINGMEMBRANE);NEWPROGNOSTICFACTORSINIDIOPATHICMACULARHOLES?
T. Sandinha, C. Geenen, D. Steel OS1-18 COMPARATIVESTUDYBETWEENPARSPLANAVITRECTOMYWITHINTERNALTAMPONADEANDEPISCLERALMACULARBUCKLINGIN CASES OF MYOPIC MACULAR HOLE RETINAL DETACHMENT
M. Alhadad, A. Bedda, A. Abd Alhada OS1-19 THEELUSIVEVITREOUSSHEATH:MYOPICHOLEWITHDETACHMENT
R. Narula, D. Talwar, A. Gupta, L. Verma OS1-20 INTRAOPERATIVEOCTASSISTEDVITREO-RETINALSURGERYWITHFOVEASPARINGINTERNALLIMITINGMEMBRANEPEELINGFOR MYOPICTRACTIONMACULOPATHY:OUREXPERIENCE
A. Kumar, R. Ravan, A. Mehta, S. Simakurthy, C. Dhull OS1-21 MACULARBUCKLINGTECHNIQUEINHIGHMYOPIA:THESTATEOFTHEART
M. Alkabes, C. Mateo OS1-22 INTRAVITREAL INJECTION OF AIR FOR THE TREATMENT OF VITREOMACULAR TRACTION
L. Agea, V. Primavera, M. Vitale, T. Centoducati, G. Alessio OS1-23 EFFICACYOFINTRAVITREALINJECTIONOFPERFLUOROPROPANE(C3F8)ANDSULFURHEXAFLUORIDE(SF6)INRELEASING VITREOMACULAR TRACTION - A COMPERATIVE STUDY
N. Cokl, M. Globocnik Petrovic
ORAL PRESENTATIONS - MEDICAL SESSION 127 April, 13:00-14:30 - ROOM ONICE3 minutes/each + 1 minute discussion
OM1-01 DETERMINATION AND COMPARISION OF URINARY IODINE LEVELS IN PATIENTS WITH AGE-RELATED MACULAR DEGENERATION AND HEALTHY VOLUNTEERS
E. Cinici, M. Gullaboglu, L. Duyzak, M. Cetin, Z. Kutlu OM1-02 OCTANGIOGRAPHYANDEXUDATIVEARMD:CORRELATIONWITHICGVIDEOANGIOGRAPHY
M. Nelson OM1-03 SHORT-TERMEFFECTSOFINTRAVITREALRANIBIZUMABANDBEVACIZUMABADMINISTRATIONON24-HOURAMBULATORYBLOOD PRESSURE MONITORING RECORDINGS IN NORMOTENSIVE PATIENTS WITH AGE RELATED MACULAR DEGENERATION
A. Sengul, R. Rasier, A. Kockar, O. Artunay, E. Yuzbasioglu OM1-04 EVALUATIONOFCHOROIDALNEOVASCULARIZATIONBEFOREANDAFTERANTI-VEGFTHERAPYUSINGOCTANGIOGRAPHY
B. Chanana, S. Bharti OM1-05 INTRAVITREALAFLIBERCEPTANDRANIBIZUMABINJECTIONSFORRETINALANGIOMATOUSPROLIFERATION
H. Cho, H. Kim, J. Han, C. Kim, D. Lee, J. Kim OM1-06 BEVACIZUMABVSRANIBIZUMABFORWETAGE-RELATEDMACULARDEGENERATIONTREATMENT:ACOSTEFFECTIVENESSANALYSIS FROM AN HIGH VOLUME REGIONAL REFFERAL CENTER
S. D’Amelio OM1-07 MEASUREMENTOFRETINALVESSELSINCENTRALSEROUSCHORIORETINOPATHYBYOCT
H. Arifoglu, O. Altunel OM1-08 SPECTRAL-DOMAINOPTICALCOHERENCETOMOGRAPHY(SD-OCT)EVALUATIONINCLUDINGEN-FACEIMAGINGOFTHEFLUORESCEIN ANGIOGRAPHICLEAKINACUTECENTRALSEROUSCHORIORETINOPATHY(CSC)
N. Goel, A. Mehta OM1-09 NEWTECHNIQUEOFTREATMENTACUTECENTRALSEROUSCHORIORETINOPATHYBASEDONSELECTIVE INFLUENCE OF SHORT LASER PULSES ON RETINAL PIGMENT EPITHELIUM
E. Ivanova, P. Volodin, G. Zheltov OM1-10 ICGA GUIDED THERMAL LASER IN CHRONIC RECURRENT CSCR
S. Prakash, R.k. Biswas, S. Sinha, S. Sanyal OM1-11 GLYCOSYLATEDHEMOGLOBINLEVELSASAPROGNOSTICFACTORINDIABETICMACULAREDEMAUNDER INTRAVITREAL ANTIANGIOGENIC TREATMENT
R. Falah, I. Alarcon Valero, D. Vilaplana Blanch, V. Poposki, S. Khaouly Alonso, M. Castilla Cespedes OM1-12 3-YEAR-DATAOFCOMBINEDNAVIGATEDLASERPHOTOCOAGULATION(NAVILAS)ANDINTRAVITREALRANIBIZUMABCOMPAREDTO RANIBIZUMABMONOTHERAPYINDMEPATIENTS
T. Herold, J. Langer, E. Vountrypidis, M. Kernt, S. Priglinger OM1-13 SIMULTANEOUSINTRAVITREALRANIBIZUMABANDDEXAMETHASONEIMPLANTADMINISTRATIONATTHESAMESETTINGINEYESWITH SEVEREDIABETICMACULAREDEMA
A. Saatci, Z. Ayhan, C. Durmaz Engin OM1-14 THEVITREOMACULARINTERFACEINEYESWITHDIABETICMACULAREDEMACORRELATEDWITHSD-OCTCLASSIFICATION
F. Hagenau, D. Compera, S. Guenther, A. Wolf, S. Priglinger, R.G. Schumann OM1-15 RETROSPECTIVE EVALUATION OF DIFFERENT TREATMENTS OF PMCE AFTER CATARACT SURGERY AND AFTER PHACOVITRECTOMY
S. Freissinger OM1-16 SLOWLYPROGRESSIVERETINITISPIGMENTOSACAUSEDBYANOVELCOMPOUNDHETEROZYGOUSMUTATIONINTHEMAKGENE
J. Gray, H.o. Orlans, R.E. Maclaren OM1-17 AN IMPROVED MODEL OF COMPLETE ACHROMATOPSIA FOR PRE-CLINICAL DEVELOPMENT OF GENE AND CELL THERAPIES
M. Hassall, A. Barnard, S. Aslam, R. Maclaren OM1-18 WIDEFIELD OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY OF IDIOPATHIC RETINAL VASCULITIS, ANEURYSMS, AND NEURORETINITIS(IRVAN)
A. Marchese, E. Miserocchi, G. Modorati, G. Fogliato, A. Rabiolo, R. Lattanzio, L. Querques, G. Querques, F. Bandello OM1-19 CLINICAL CASE REPORT OF CYTOMEGALOVIRUS RETINITIS ASSOCIATED WITH APLASTIC ANEMIA
B. Pershin, A. Smirnova, L. Shelihova, A. Dugina, A. Maschan, V. Mahmutov OM1-20 SD-OCTINTHEEVALUATIONANDMANAGEMENTOFMULTIFOCALSERPIGINOEDCHORODITIS(MSC)
E. Abo Taleb, M. Nagpal, N. Mehorate OM1-21 THE IMPORTANCE OF FUNDUS AUTOFLUORESCENCE IMAGING FOR EVALUATING ARGUS II PATIENTS
N. Koyluoglu, O. Sahin, Y.z. Arslan, R. Arslantas, I. Pallikaris
27
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
26
ORAL PRESENTATIONS - SURGICAL SESSION 230 April, 08:00-09:30 – ROOM VERDE3 minutes/each + 1 minute discussion
OS2-01 THETIMINGANDEFFECTIVENESSOFBEVACIZUMABPRE-VITRECTOMYFORADIABETIC‘VASCULARTRACTIONALRETINALDETACHMENT’: ANOCTANGIOGRAPHYBASEDPERSPECTIVE
A. Jalil, A. Papayannis, S. Chng, E. Tsamis, F. Stringa, P. Stanga OS2-02 NEGATIVE STAINING OF THE VITREOUS WITH THE USE OF COHESIVE VITAL DYE
M. Nicolai, M. Reibaldi, V. Pirani, P. Pelliccioni, R. Mastropasqua, C. Mariotti OS2-03 MEMBRANEBLUEDUALASASURGICALADJUNCTFORRETINALGENETHERAPYSURGERY:ANINVITROANDINVIVOANALYSIS
A. Salvetti, H. Orlans, M. Patrício, A. Barnard, D. Hickey, R. Maclaren OS2-04 EX VIVO AAV-MEDIATED GENE EXPRESSION IN THE HUMAN RETINA
H. Orlans, T. Edwards, M. Patricio, R. Maclaren OS2-05 SUBRETINALGENETHERAPYWITHINTRAOPERATIVEOCTGUIDANCE
K. Xue, A.P. Salvetti, A.R. Barnard, R.E. Maclaren OS2-06 ANTERIORCHAMBERSF6INJECTIONFORTHEMANAGEMENTOFHYPOTONYINGLAUCOMAPATIENTS
S. Gotzaridis, D. Portaliou, V. Mela, P. Xanthopoulou OS2-07 FILL THE UGLY DIMPLES
S. Arora OS2-08 27-GAUGE VITRECTOMY FOR VITREORETINAL DISORDERS
C. Falkner-Radler, E. Bukaty, I. Krebs OS2-09 ANATOMICALOUTCOMESOFVITRECTOMYWITHINTERNALLIMITINGMEMBRANEPEELINGINCASESOFRHEGMATOGENOUSRETINAL DETACHMENT.
E. El Baha Samir, L. Lolah Mohamed, A. Mahmoud Abouhussein OS2-10 PNEUMORETINOPEXYWITHSUB-RETINALFLUIDDRAINAGEINTREATMENTOFBULLOUSRHEGMATOGENOUSRETINALDETACHMENT.
R. Soibam, H. Bhattacharjee, M.J. Barman, D. Pandey OS2-11 RETINAL DETACHMENT ASSOCIATED WITH MACULAR HOLE IN HIGHLY MIOPIC EYE
P. Rossini, A. Volinia, A. Bratu, A. Saitta, D. D’Eliseo OS2-12 RETINALRE-DETACHMENTANDSUB-RETINALPROLIFERATIONINMYOPICEYEAFTERPRIMARYPPVANDHDSILICONOILTAMPONADE FOR INFERIOR RETINAL DETACHMENT
V. Dzinic OS2-13 LOSS OF LIGHT PERCEPTION AFTER PARS PLANA VITRECTOMY FOR RHEGMATOGENUOUS RETINAL DETACHMENT
H. Güngel OS2-14 27G VITRECTOMY FOR STAGE 4 ROP TREATMENT
M. Chizzolini OS2-15 ENDOSCOPE- ASSISTED AND GUIDED ARGUS II EPIRETINAL PROSTHESIS IMPLANTATION IN LATE-STAGE RETINITIS PIGMENTOSA
E. Özmert OS2-16 VITRECTOMY WITH ARTERIAL SHEATHOTOMY AS A PRIMARY TREATMENT OPTION IN CENTRAL RETINAL ARTERY OCCLUSION
N. Borse, V. Borse, V. Prasad OS2-17 LIGHT PERCEPTION IS A GREAT HOPE. NOVEL TECHNIQUE FOR POSTERIOR RUPTURE REPAIR
M. Ashraf OS2-18 INTRAOPERATIVEB-SCANULTRASONOGRAPHYANDPARSPLANAVITRECTOMYFORSEVEREOPENGLOBENJURYWITHHEMORRHAGIC RETINAL AND CHOROIDAL DETACHMENT
T. Wakabayashi, N. Shiraki, H. Sakaguchi OS2-19 METHOD FOR SURGICAL TREATMENT THE CHOROID RUPTURE IN DURING POSTTRAUMATIC RECONSTRUCTION OF THE EYE
O. Unguryanov OS2-20 TRAUMA OF POSTERIOR SEGMENT OF THE EYE IN OUR REGION
O. Ates, A.N. Kok, I. Kocer OS2-21 ENBLOCRESECTIONFORSEVERERETINALCAPILLARYHEMANGIOBLASTOMA
M. Karacorlu
ORAL PRESENTATIONS - MEDICAL SESSION 230 April, 08:00-09:30 – ROOM ONICE3 minutes/each + 1 minute discussion
OM2-01 OPTIMIZATIONOFPRLWITHFONDAFARPRISMSANDMICROPERIMETRYD. Cacciatore, S. Volanti
OM2-02 INVERSEASSOCIATIONBETWEENHIGHBLOOD25-HYDROXYVITAMINDLEVELSANDDIABETICRETINOPATHYINAREPRESENTATIVE KOREAN POPULATION
D. JeeOM2-03 DIABETICRETINO-CHOROIDOPATHY:AUTOMATEDMORPHO-FUNCTIONALASSESSMENT
M. Lupidi, C. Cagini, F. Coscas, T. Fiore, M. Nicolò, F. Cardillo Piccolino, G. Coscas OM2-04 DIABETICMACULARISCHEMIAFEATURESUSINGOPTICALCOHERENCETOMOGRAPHYANGIOGRAPHY(OCT-A)
A. Minnella, M.c. Savastano, M. Federici, V. Pagliei, A. Lanza, L. Barbano, B. Falsini, A. Caporossi OM2-05 SUBTHRESHOLDYELLOWMICROPULSEDLASERINCHRONICMACULARDISEASESWITHOUTTHERAPEUTICINDICATIONS
F. Passani, R. Denaro, A. Passani, A. Sframeli OM2-06 PASCALGRIDMODIFIEDLASER(GML)TREATMENTINCLUDINGSUBTHRESHOLDSTRATEGY(SS)INTHETREATMENTOFSEVEREDIFFUSE CYSTOIDMACULAREDEMA(SDCME)INNONPROLIFERANTDIABETICRETINOPATHY(NPDR).
G. Pacelli, G. Macri’, C. Pisano, L. Baraggia, V. Belloli OM2-07 MANAGINGLASERPHOTOCOAGULATIONINDUCEDAPNEAWITHPERIBULBARANAESTHESIAINVERYLOWBIRTHWEIGHTBABYWITH THRESHOLDRETINOPATHYOFPREMATURITY(ROP).
S. Arya, L.S. Jhala OM2-08 ULTRAWIDEFIELD(UWF)IMAGINGOFFAMILIALEXUDATIVEVITREORETINOPATHY(FEVR)
V. Kumar, R. Tewari OM2-09 SEMI-AUTOMATED SCANNING PATTERN LASER PHOTOCOAGULATION IN THE PREVENTIVE TREATMENT FOR PERIPHERAL RETINAL DEGENERATIONS IN CHILDREN
P. Volodin, A. Semenov, I. Yablokova OM2-10 OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN TYPE-2 MACULAR TELENGIECTASIA
F. Sermet, H. Nalci, S. Demirel, E. Ozmert OM2-11 ABDOMINALAORTICANEURISMASSOCIATEDWITHRETROHYALOIDHEMORRHAGE
M. Arroyo Castillo, N. Olivier Pascual, J. Viéitez Vázquez OM2-12 REPRODUCIBILITYANDRELIABILITYOFOPTICALCOHERENCETOMOGRAPHYANGIOGRAPHYFORFOVEALAVASCULARZONEEVALUATION AND MEASUREMENT IN DIFFERENT SETTINGS
C. La Spina, A. Carnevali, A. Marchese, G. Querques, F. Bandello OM2-13 MULLERCELLSANDINTRARETINALCHANGESAFTERDIABETICVERSUSIDIOPATHICMACULARPEELING
M. Ferrara, G. Cennamo, M.R. Romano OM2-14 MIRNASINVITREOUSHUMOROFPATIENTSAFFECTEDBYIDIOPATHICEPIRETINALMEMBRANEANDMACULARHOLE
V. Pirani, C. Mariotti, A. Russo, T. Avitabile, M. Nicolai, M. Reibaldi OM2-15 ASSOCIATIONOFAXIALLENGTHANDCORTICALVITREOUSMORPHOLOGYASASSESSEDBYSWEPTSOURCEOPTICALCOHERENCE TOMOGRAPHY
M. Engelbert OM2-16 OCT ANGIOGRAPHY PRELIMINARY STUDY OF SUPERFICIAL AND DEEP RETINAL CHANGES AFTER MACULAR PEELING
A. Baldascino, G.m. Amorelli, C. Radini, O. Caporossi, A. Caporossi OM2-17 COMPARISONOFTHEEFFECTOFBLUNTTRAUMAONVITRECTOMIZEDANDNON-VITRECTOMIZEDRABBITEYES
M. Batur, E. Seven, S. Tekin, T. Yasar OM2-18 OCULARULTRASOUND(OUS)ASANEASYAPPLICABLETOOLFORDETECTIONOFTERSON’SSYNDROMEAFTERANEURYSMAL SUBARACHNOIDHEMORRHAGE(SAH).
C. Skevas, P. Czorlich, L. Wagenfeld, T. Burkhardt, M. Westphal, G. Richard, J. Regelsberger OM2-19 COMBINEDHAMARTOMAOFRETINAANDRETINALPIGMENTEPITHELIUM:OCTPROVIDESNEWINSIGHTS
R. Chawla, A. Kumar, P. Venkatesh, V. Agarwal, K. Tripathy OM2-20 REAL-TIME IN VIVO MICROMORPHOLOGY AND HISTOPATHOLOGY OF CHOROIDAL OSTEOMA USING ENHANCED DEPTH IMAGING
R. Hussain OM2-21 COMPLICATIONS IN VITREOMACULAR TRACTION EYES FOLLOWING OCRIPLASMIN INJECTION
J. Langer, D. Compera, W.j. Mayer, S. Priglinger, R.g. Schumann
29
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
28
POSTER PRESENTATIONS 1 - MEDICAL RETINA28 April, 16:45-17:15 – POSTERS AREA
PM-01 THREE-YEAROUTCOMESOFINTRAVITREALAFLIBERCEPTINJECTIONFORTREATMENTNAÏVENEOVASCULARAGE-RELATEDMACULAR DEGENERATION
M. Kimura, Y. Nagai, M. Ohnaka, K. Fujita, T. Chihara, K. Nakagawa, K. Takahashi PM-02 NASCENTGEOGRAPHICATROPHYOFCHOROID(NGA):ANGIOOPTICALCOHERENCETOMOGRAPHY(AOCT)ANDRETINALFLUORESCEIN ANGIOGRAPHY(FAG)INTWOCLINICALCASES
S. Brogelli PM-03 EFFECTSOFSWITCHINGFROMRANIBIZUMABTOAFLIBERCEPTINEYESWITHPERSISTENTEXUDATIVEAMD
R. Giannini, T. Mascaro, A. Mauro, L. Zompatori PM-04 FEATURESOFNON-EXUDATIVECHOROIDALNEOVASCULARIZATIONINAGE-RELATEDMACULARDEGENERATIONWITHOPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
Y. Nagai, M. Ohnaka, K. Nakagawa, K Fujita, M. Kimura, T. Chihara, K. Takahashi PM-05 MULTI-IMAGINGANALYSISOFCHOROIDALNEOVASCULARIZATIONINWETAGE-RELATEDMACULARDEGENERATION.OPTICALCOHERENCE TOMOGRAPHYANGIOGRAPHYCONTRIBUTION
M. Fernández Rodríguez, P. Santos Ramos, M. Gil Martinez, F. Gómez-Ulla De Irazazabal PM-06 REAL WORLD OUTCOMES OF TREAT-AND-EXTEND AND PRO RE NATA DOSING STRATEGIES VERSUS MONTHLY DOSING FOR NEOVASCULARAGERELATEDMACULARDEGENERATIONUSINGRANIBIZUMAB:ALITERATUREREVIEWANDECONOMICANALYSIS
S. Rufai, H. Hamami PM-07 CHANGE OF RETINAL PIGMENT EPITHELIAL ATROPHY AFTER ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR TREATMENT IN EXUDATIVE AGE-RELATED MACULAR DEGENERATION
M. Kim PM-08 TOSTUDYTHESAFETYANDEFFICACYOFTHEFIRSTRANIBIZUMABBIOSIMILARININDIA
N. Borse, V. Borse PM-09 INTRAVITREALANTI-VEGFTHERAPYINACASEOFCHOROIDALNEOVASCULARIZATIONASSOCIATEDWITHPSEUDOXANTHOMAELASTICUM
M. Fruschelli, G. Haka, M. Capozzoli, S. Fazio PM-10 CLINICALOUTCOMESOFALDOSTERONRECEPTORANTAGONISTS:AREALLIFESTUDY
I. Zucchiatti, D. Montorio, A. Carnevali, R. Sacconi, C. Giuffrè, A. Rabiolo, L. De Vitis, L. Querques, G. Querques, F. BandelloPM-11 SPIRONOLACTONE VERSUS HALF-DOSE PHOTODYNAMIC THERAPY FOR CHRONIC CENTRAL SEROUS CHORIORETINOPATHY
C. Lee, J. Lee S. Lee PM-12 MULTIFOCALELECTRORETINOGRAPHY(MF-ERG)ASSISTEDEVALUATIONOFCONSERVATIVEMANAGEMENTVERSUSSUBTHRESHOLD LASERINACUTECENTRALSEROUSCHORIORETINOPATHY(CSC)
N. Goel, A. Mehta PM-13 THEEFFECTIVENESSOFINTRAVITREALSTEROIDINJECTIONINTHEDIABETICMACULAREDEMA,NON-RESPONSIVETOTHE INTRAVITREALBEVACIZUMABINJECTION
D. Lee, J. Han PM-14 DEXAMETHASONEINTRAVITREALIMPLANTFORTREATMENTOFUNRESPONSIVEDIABETICMACULAREDEMA:RISKFACTORSIMPORTANCE
E. Perez-Salvador Garcia, A. Sanchez Ramon, E. Ortega Alonso, I. Roberts Martinez-Aguirre, M. Lopez Galvez PM-15 THESHORTTERMRESULTSOFINTRAVITREALDEXAMETHASONEIMPLANT(OZURDEX®)INTHETREATMENTOFPERSISTENTDIABETIC MACULAR EDEMA
C. Caglar PM-16 COMPARISONOFDIFFERENTAPPROACHESINTREATMENTOFCHRONICDIABETICMACULAROEDEMA:INTRAVITREALAFLIBERCEPT VERSUS TRIAMCINOLONE ACETONIDE INJECTION
M. Karliychuk, S. Pinchuk, O. Baryska PM-17 OUTCOMESOFSWITCHINGTREATMENTTOAFLIBERCEPTINPATIENTSWITHDIABETICMACULAROEDEMAREFRACTORYTORANIBIZUMAB
V. Konidaris, K. Pieri, Z. Al-Hubeshy, J. Deane, T. Empeslidis, K. Tsaousis PM-18 COMPARISON OF MICROANEURYSM TURNOVER AND CENTRAL MACULAR THICKNESS CHANGES AFTER INTRAVITREAL DEXAMETHASONE IMPLANTANDINTRAVITREALBEVACIZUMABINJECTIONASATREATMENTOFDIABETICMACULAREDEMA
W. Jung, J. Park, S. Lee PM-19 SUBTHRESHOLDYELLOWMICROPULSEDLASER:CASEREPORTANDMECHANISMOFACTION
R. Denaro, F. Passani, A. Sframeli, A. Passani PM-20 DISTRIBUTIONANDDIVERSITYOFOCULARMICROBIALCOMMUNITIESINPATIENTSWITHPROLIFERATIVEDIABETICRETINOPATHYCOMPA REDWITHHEALTHYSUBJECTS
K.D. Kang, M.J. Kwon, S.A. Kim PM-21 RISKFACTORSFORDEVELOPMENTANDPROGRESSIONOFRETINOPATHYINNORMOALBUMINURICTYPE1DIABETICPATIENTS
M. Tomic, R. Vrabec, K. Blaslov, T. Bulum, L. Duvnjak PM-22 VOMITINGINDUCEDBLEEDINPROLIFERATIVEDIABETICRETINOPATHY
R. Tewari, V. Kumar, P. Chandra, A. Kumar PM-23 PAPILLARYNEOVASCULARIZATIONINPROLIFERATIVEDIABETICRETINOPATHYBYOPTICALCOHERENCETOMOGRAPHYANGIOGRAPHY
A. Minnella, M. Federici, M.C. Savastano, V. Pagliei, G. Gambini, G. Amorelli, B. Falsini, A. Caporossi PM-24 INTEROCULARASYMMETRYOFGANGLIONCELL–INNERPLEXIFORMLAYER(GC-IPL)THICKNESSASSIGNOFRETINOPATHY PROGRESSIONINDIABETICPATIENTS:SPECTRALDOMAINOPTICALCOHERENCETOMOGRAPHY(SD-OCT)STUDY
J. Kim, H.B. Lim, Y.I. Shin
PM-25 LAMINACRIBROSATHICKNESSINPATIENTSWITHTYPE2DIABETESMELLITUSDEPENDINGONTHEGLICOLIZEDHAEMOGLOBINLEVELM. Karliychuk, P. Besditko
PM-26 THEEFFECTSOFBEVACIZUMABINTRAVITREALINJECTIONANDDEFERREDLASERTREATMENTONRETINALVASCULATUREIN RETINOPATHY OF PREMATURITY
S. Lee, K.y. Nam PM-27 BEVACIZUMABFORROP.RETCAMFOLLOWUP
I. Sánchez Santos, P. Pontón Méndez, N. Gajate Paniagua, R. Hernández Rodríguez, A. Sánchez Ramón, R. Renato Portilla, E. Zarzosa Martín, I. Martínez Aguirre, L. Macías Molinero, R. Piñón Mosquera
PM-28 INVESTIGATIONOFTHERELATIONSHIPBETWEENLEVELSOFCHMGENEEXPRESSIONANDRATEOFDISEASEPROGRESSIONINCHOROIDEREMIAM. Patricio, K Xue, L.C. Chandler, A.R. Barnard, J.K. Jolly, T. Edwards, M.E. Mcclements, R.E. Maclaren
PM-29 ACUTEWORSENINGOFCYTOMEGALOVIRUSRETINITISFOLLOWINGSUB-TENON’SINJECTIONOFTRIAMCINOLONEACETONIDEIN IMMUNOCOMPETENT PATIENTS
M. Nozaki, M. Yoshida, A. Kato, Y. Ogura PM-30 CLINICALSIGNIFICANCEOFTOXOPLASMAGONDII-SPECIFICIMMUNOGLOBULINMHIGHSERUMANTIBODYTITERSINUVEITISPATIENTS
S. Park, S. Kim, H. Kwon, I. Byon, J. Lee PM-31 THERAPEUTIC TRIAL IN YOUNG PATIENT SUSPECTED OF RETINAL TOXOPLASMOSIS
R. Hernández Rodríguez, R.R. Portilla Blanco, P. Pontón Mendez, E. Zarzosa Martín, L. Fernández Cherkásova, A. Sanchez Ramon, I.M.J Sanchez Santos, I. Roberts Aguirre, J. Olea Cascón
PM-32 CASEREPORT:BILATERALMULTIPLEEXUDATIVERETINALDETACHMENTSDUETOPRESUMEDVOGT-KOYANAGI-HARADA(VKH)DISEASE.R. Portilla Blanco, R. Hernández Rodríguez, I. Sánchez Santos, A. Sánchez Ramón, Y. Lantigua Dorville
PM-33 BILATERALENDOGENOUSENDOPHTHALMITISTREATEDBYINTRAVITREALVORICONAZOLEN. Olivier Pascual, R. Arroyo Castillo, J. Viéitez Vázquez
PM-34 ACUTERETINALNECROSIS:COMBINEDTREATMENTWITHINTRAVENOUSACICLOVIRANDINTRAVITREALGANCICLOVIR.N. Olivier Pascual, M. Arroyo Castillo, J. Viéitez Vázquez, B. De Domingo Barón
PM-35 A NOVEL CASE OF CLOSTRIDIUM PERFRINGENS ENDOPHTHALMITIS POST ANTI-VEGF INJECTION Y. Bandeh Moghaddam, V. Kadaba, V. Menon
PM-36 BILATERALMACULARINFARCTIONINANTIPHOSPHOLIPIDSYNDROMES. Kim, Y. Kim
PM-37 MACULARPIGMENTOPTICALDENSITY(MPOD)MEASUREMENTFOREARLYDETECTIONOFHYDROXYCHLOROQUINERETINALTOXICITYV. Subrayan, P.W Lott, K.R Lee
PM-38 MACULARPIGMENTOPTICALDENSITY(MPOD)INPATIENTSONHYDROXYCHLOROQUINEK.R. Lee, V. Subrayan, S. Ghazali, M. Hassan
PM-39 LONG-TERMREPRODUCIBILITYOFSPECTRALDOMAINOPTICALCOHERENCETOMOGRAPHYMEASUREMENTSINEYESWITHHIGHMYOPIAM. Lee, K.S. Kim, J.Y. Kim
PM-40 RETINALSTRIAE,ACUTEMYOPIA,ANDACUTEANGLECLOSUREGLAUCOMA(ACG)INAPATIENTRECENTLYSTARTEDONTOPIRAMATE:A CASE REPORT
P. Hughes, G. Almeida PM-41 RETINAL THINNING CORRELATES WITH CLINICAL SEVERITY IN MULTIPLE SYSTEM ATROPHY
T. Kim, J. Ahn, J-Y Lee PM-42 OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY FINDINGS IN RETINAL VEIN OCCLUSION
F. Gómez-Ulla, M. Diez, M. Abraldes, M.J. Rodríguez, M. Fernández PM-43 CHOROIDALMELANOMAARAREDIAGNOSISINALBANIA(CASEREPORT)
E. Qerimi, D. Qerimi PM-44 RETINALCAPILLARYHEMANGIOMAASSOCIATEDWITHRETINOCHOROIDALCOLOBOMAINVONHIPPEL-LINDAUDISEASE
P. Mishra, K. Sharma, V. Kanaujia PM-45 ANTERIORDIFFUSEINFILTRATINGRETINOBLASTOMAWITHOUTADEFINITIVERETINALMASS:ANULTRAWIDEFIELDIMAGINGSTUDY
S. Tiple, S. Das, S. Bansal PM-46 ACASEOFCEREBELLARHEMANGIOBLASTOMA.VONHIPPELLINDAUSYNDROME
G. Vecchione PM-47 MACULOPATHY ASSOCIATED WITH PERIPHERIAL CHOROIDAL MELANOMA
H. Zargaryan, A. Brovkina PM-48 CASEREPORT:EXUDATIVERETINALDETACHMENTPRESUMEDTOBESECONDARYTOLEFTINTRAORBITALMETASTATICTUMOR.
R. Portilla Blanco, R. Hernández Rodríguez, P. Pontón Méndez, L. Fernández Cherkasova, E. Pérez-Salvador García PM-49 BLURREDVISIONASTHEPRESENTINGCOMPLAINTOFLUNGADENOCARCINOMA:ACASEREPORTANDLITERATUREREVIEW.
N. Gajate Paniagua, L. Fernandez Cherkasova, R. Portilla Blanco, P. Ponton Méndez, A. Sánchez Ramón PM-50 VITREORETINAL SURGERY FOR OCULAR COMPLICATIONS OF CHRONIC MYELOID LEUKAEMIA
L. Fernandez, M.J. Lopez Peña, R. Hernandez, I. Roberts, E. Zarzosa PM-51 DIAGNOSTICCHALLENGE:NON-PIGMENTEDCILIOCHOROIDALMELANOMAPRESENTEDASRETINALANDCHOROIDALDETACHMENT
N. Munoz Sanz, A. Jalil PM-52 STEROTACTICRADIOSURGERYINUVEALMELANOMA:LONGTERMRESULTS
C. Mazzini, A. Miele, G. Pieretti, A. Giorni, S. Rizzo PM-53 CHOROIDAL VASCULARITY INDEX IN PATIENTS WITH SYSTEMIC HYPERTENSION
S. Kadayifcilar, Z. Massiyeva, O. Inam, B. Eldem
31
FINAL PROGRAM Florence (Italy) 27-30 April 2017 FLOREtina 2017 Florence Retina Meeting
30
PM-54 HYPERBARICOXYGENTHERAPYOFCILIORETINALARTERYOCCLUSIONINTHELATEPERIODS. Dundar, H. Cakmak, T. Kocaturk
PM-55 PERIPAPILLARYANDFOVEALCHOROIDALTHICKNESSEVALUATIONOFBETATHALASSEMIAPATIENTSB. Can Ermerak, O. Yalcinbayir, B. Baytan, M. Sezgin Evim
PM-56 RETINALCAPILLARITISINACRB1-ASSOCIATEDRETINALDYSTROPHYV. Murro, D. P. Mucciolo, A. Sodi, L. Vannozzi, C. De Libero, G. Simonini, S. Rizzo
PM-57 COATS’DISEASEWITHBILATERALFINDINGSG. Ture, S. Adiyeke, P. Ozdal, E. Talay
PM-58 SHE LOST HER SECOND CHANCE R. Hernández Rodríguez, R.R. Portilla Blanco, P. Pontón Medez, I.M.J. Sanchez Santos, L. Fernández Cherkásova, A. Sanchez Ramon, E. Zarzosa Martín,I. Roberts Aguirre, J. Alonso Maroto
PM-59 THEBLOODHASTHEANSWERR. Hernández Rodríguez, R.R. Portilla Blanco, E. Zarzosa Martín, P. Pontón Mendez, L. Fernández Cherkásova, A. Sanchez Ramon, I.M.J Sanchez Santos,I. Roberts Aguirre, N. Gajate Paniagua
PM-60 AHARDLYTRUSTWORTHYARTERIALOCCLUSION:THEGREATSIMULATORATTACKSAGAINP. Ponton Mendez, I. Sanchez Santos, R.R. Portilla Blanco, R. Hernandez Rodriguez, C. Gordon Bolaños, L. Macías Molinero, I. Roberts Martinez-Aguirre,E. Zarzosa Martin, A. Sanchez Ramon, L.J. Fernandez Cherkasova
PM-61 CONTRASTENHANCEDMAGNETICRESONANCEANGIOGRAPHYINYOUNGPATIENTSAFFECTEDBYRETINALVEINOCCLUSIONR.Tartaro, A.Sodi, A.Giorni, G.Pellicanò, E.Fainardi, S.Rizzo
POSTER PRESENTATIONS 2 – SURGICAL RETINA29 April, 16:31-17:00 – POSTERS AREA
PS-01 FOUR-PORTBIMANUAL23-GAUGEVITRECTOMYFORDIABETICTRACTIONALRETINALDETACHMENTM. Tawfik
PS-02 DIABETICVITRECTOMYFORTRACTIONALDETACHMENTS:WHENTOSTOP?R. Chawla, A. Kumar, P. Venkatesh, R. Vohra
PS-03 STANDARD3PORTPRIMARYPARSPLANAVITRECTOMYFORMANAGINGDIABETICCOMBINEDRHEGMATOGENOUSANDTRACTIONAL RETINAL DETACHMENT
S. Arya, V.R. Saravanan PS-04 DIABETICVITRECTOMYFELLOWEYESTUDY
P. Scollo, C. Svasti-Salee, R.S.B. Newsom, L. Sullivan, D.M. Hornan PS-05 ANALYSISOFFIBROTICMARKERSINMACULARPUCKERANDPROLIFERATIVEVITREORETINOPATHY
S. Guenther, D. Compera, A. Wolf, F. Hagenau, S. Priglinger, R.G. Schumann PS-06 SURGICALOUTCOMESOFEPIRETINALMEMBRANECONTAININGMACULARPIGMENT-SPARINGVITRECTOMYFORLAMELLARMACULARHOLE
T. Kawaji,, T. Sato A. Takano PS-07 PROGRESSION OF LAMELLAR HOLE-ASSOCIATED EPIRETINAL PROLIFERATION AND RETINAL CHANGES IN LAMELLAR MACULAR HOLES DURING LONG TIME FOLLOW-UP
D. Compera, R.G. Schumann, M. Cereda, A. Acquistapace, V. Lita, S. Priglinger, G. Staurenghi, F. Bottoni PS-08 FREE FLAP FOR FAILED MACULAR HOLE SURGERY
R. Narula, A. Gupta, D. Talwar, L. Verma PS-09 HOLE-DOORSIGN:ANOVELINTRAOPERATIVEOPTICALCOHERENCETOMOGRAPHY(IOCT)FEATUREPREDICTINGPOSTOPERATIVE MACULAR HOLE CLOSURE
V. Kumar PS-10 FAILED MACULAR HOLE SURGERY
E. El Baha Samir PS-11 EN-FACESPECTRAL-DOMAINOCT(SD-OCT)CHARACTERISTICSOFTHEINNERRETINALSURFACEAFTERINTERNALLIMITINGMEMBRANE (ILM)PEELINGFORMACULARHOLE
N. Goel PS-12 VITRECTOMYFOROPTICPITRETINALDETACHMENT(VIDEO)
F. Balta PS-13 SURGICALOUTCOMESOFINVERTEDINTERNALLIMITINGMEMBRANEFLAPTECHNIQUEFORLARGEMACULARHOLES
L. Prochazkova, M. Zavorkova PS-14 EVOLUTION OF MACULAR HOLE
A. Soni, A. Dhawan, A. Agarwal PS-15 INTRA-OPERATIVE-OCT GUIDED, INVERTED FLAP TECHNIQUE OF MACULAR HOLE CLOSURE
A. Kumar, R. Chawla, P. Kakkar, A. Mehta PS-16 INTRA-OPERATIVE-OCTGUIDEDINTERNALLIMITINGMEMBRANEPEELINGWITHINVERSIONOFILMINTOOPTICDISCPITFORCASESOF OPTIC DISC PIT ASSOCIATED MACULOPATHY
A. Kumar, R. Chawla, R. Ravani, K. Chatra PS-17 DISPLACEMENT OF THE FOVEA ASSESSED USING EN-FACE OPTICAL COHERENCE TOMOGRAPHY IMAGES AFTER MACULAR HOLE SURGERY
J. Lee, S.M. Lee, S.W. Park, I.S. Byon PS-18 THEMICROSTRUCTURALCHANGESOFFOVEAFOLLOWINGAUTOLOGOUSINTERNALLIMITINGMEMBRANETRANSPLANTATIONSURGERY FOR LARGE MACULAR HOLE
I. Byon, S. Lee, H. Kwon, S. Park, J. Lee
PS-19 MICROINSCISIONVITRECTOMYSURGERYWITHINTERNALLIMITINGMEMBRANEPEELINGFORRHEGMATOGENOUSRETINAL DETACHMENT IN HIGH MYOPIC EYES
D. Talwar, S. Butola, S. Arora, R. Narula, A. Gupta PS-20 PARSPLANAVITRECTOMYWITHINTERNALLIMITINGMEMBRANEPEELINGFORMYOPICFOVEOSCHISIS:RESULTSAT1YEARFOLLOW-UP
L. Finocchio, F. Giansanti, M. Vannucchi, G. Cocci, G. Virgili, S. Rizzo PS-21 SPECTRALDOMAINOPTICALCOHERENCETOMOGRAPHY(SD-OCT)CHANGESFOLLOWINGVITRECTOMYFORLONGSTANDING PRE-MACULAR HAEMORRHAGE
V. Kumar PS-22 AQUANTITATIVEANALYSISOFTHEFOVEALAVASCULARZONEANDVASCULARDENSITYINDIABETICPATIENTSWITHOUTDIABETIC RETINOPATHY USING OPTICAL COHERENCE TOMOGRAPHY ANGIOGRAPHY
P. Puzo, G. Giuliani, A. Pascale, G. Sborgia, A. Niro, N. Recchimurzo, G. Alessio PS-23 SCLERALBUCKLEWITHVARIABLEINDENTATIONASTREATMENTOFREGMATOGENOUSRETINALDETACHMENT
S. Matteini, p. Tassinari, p. Perri PS-24 EFFECT OF DURATION OF MACULAR DETACHMENT ON VISUAL ACUITY AFTER PARS PLANA VITRECTOMY FOR PRIMARY MACULA-OFF RHEGMATOGENOUS RETINAL DETACHMENT
H. Kim, D. Kim, C. Yoon, K. Kim PS-25 NATURALCOURSEOFARETINALFOLDFOLLOWINGRETINALDETACHMENTSURGERY:ALONGTERMFOLLOW-UP
H. Oner, M. Kaya, T. Ozturk, Z. Ayhan PS-26 OUTCOME AND SD-OCT MACULAR FINDING FOLLOWING SURGERY IN MACULA ON GIANT RETINAL TEAR DETACHMENT.
E. Abo Taleb, M. Nagpal, N. Mehorate PS-27 VITRECTOMY UNDER SILICONE
E. El Baha Samir PS-28 THERAPY OF INTRAVITREAL MEDICAL THERAPY-ASSOCIATED RETINAL DETACHMENT
S. Freissinger PS-29 RETINAL DETACHMENT IN FALCINELLI’S MODIFIED OSTEOODONTOKERATOPROSTHESIS
P. Rossini, A. Volinia, A. Bratu, A. Saitta, P. Colliardo, D. D’Eliseo PS-30 OUTCOMESOF27GPARSPLANAVITRECTOMYONRHEGMATOGENOUSRETINALDETACHMENTWITHSUBRETINALFLUIDDRAINAGE SOLELYATORIGINALRETINALBREAKS
A. Shinsuke, S. Ogawa, Y. Miura, K. Shiraki PS-31 EXTRAFOVEALMACULARHOLEANDPERSISTENTSUBRETINALFLUIDAFTERANUNEVENTFULFOVEASPLITTINGRETINALDETACHMENT REPAIRWITH23GAUGEVITRECTOMYAND360ºSCLERALBUCKLE.
N. Munoz Sanz, J.M. Serrano De La Iglesia PS-32 THEUTILITYOFSCLERALBUCKLINGINRHEGMATOGENOUSRETINALDETACHMENTREPAIRANDITSROLEINTHESURGICALTRAINING OF VITREORETINAL FELLOWS
A. Mehta, B. Johnson PS-33 SURGICAL OUTCOME AND INCIDENCE OF RECURRENT RETINAL DETACHMENT AFTER SILICON OIL REMOVAL IN GIANT RETINAL TEAR RETINAL DETACHMENT
E. Abo Taleb, M. Nagpal, N. Mehorate PS-34 27-GAUGE PARS PLANA VITRECTOMY FOR AN INVETERATE MYOPIC RETINAL DETACHMENT
M. Coppola, M.V. Cicinelli PS-35 ATTITUDECHANGESWITHSTRONGNEIGHBOUR
S. Arora, D. Talwar PS-36 INVITROBIOCOMPATIBILITYOFNEWHYDROGELSASVITREOUSBODYSUBSTITUTES
G. Greco, S. Lamponi, G. Leone, M. Consumi, A. Magnani PS-37 TOENHANCETHEPOTENTIALOFBRILLIANTBLUEG(BBG)FORINTRAOPERATIVESTAININGOFTHEINTERNALLIMITINGMEMBRANE(ILM) WITH RESPECT TO CONTRAST USING A STAIN – PICK – STAIN METHOD
N. Borse, V. Borse, V. Prasad PS-38 A NOVEL SURGICAL TECHNIQUE FOR THE MANAGEMENT OF SUPRACHOROIDAL HEMORRHAGE
S. Kaynak, T. Ozturk, M. Kaya, Z. Ayhan, N. Kocak PS-39 SAFEMETHODFORREMOVALOFMAGNETICMETALICINTRAOCULARFOREIGNBODY
S. Dabour, M. Tawfik PS-40 SPONTANEOUS RESOLUTION OF TRAUMATIC MACULAR RETINOSCHISIS AFTER TRAFFIC ACCIDENT
E. Perez-Salvador Garcia, E. Ortega Alonso, M.J. Lopez Peña, L. Alonso Bañuelos, I. Roberts Martinez-Aguirre, M.E. Zarzosa Martin PS-41 NOTOUCHTECHNIQUEFOROZURDEXREMOVAL
A. Soni, A. Dhawan, A. Venkataraman ,A. Agarwal PS-42 COMPARATIVE STUDY OF ENDOTHELIAL CELL LOSS USING INFINITI VERSUS SIGNATURE MACHINES IN PHACOEMULSIFICATION IN SENILE CATARACT
A. Noureldine PS-43 COMPLICATIONS AND THEIR MANAGEMENT FOLLOWING THE ARGUS II RETINAL PROSTHESIS IMPLANTATION.
S. Rizzo, L. Cinelli, A. Savastano, M. Pellegrini, A. Giorni PS-44 SUBDIVISIONALPACHYMETRYANDKERATOMETRYCHANGESINKERATOCONUSPOST-COLLAGENCROSSLINKING
K. Lee, V. Subrayan, F. Muhammad, M. Peyman PS-45 THE RESULTS OF SURGICAL TREATMENT OF TRACTIONAL MACULAR EDEMA AFTER PHACOEMULSIFICATION OF AGE-RELATED CATARACT
V. Rudenko, E. Sorokin, V. Egorov PS-46 AHMEDGLAUCOMAVALVESURGERYINVITRECTOMIZEDEYES……THISISNOTTHEEND!
B. Chanana, S. Bharti PS-47 EXPERIENCE OF RESIDENCY TRAINING FOR VITREORETINAL DISEASE IN THAILAND
N. Kanchanaranya, N. Sirikarnjanapol
FLOREtina 2017 Florence Retina Meeting
32
A C K N O W L E D G M E N T S
AMO ITALY
AKTIVE
ALFA INTESINDUSTRIA TERAPEUTICA SPLENDORE
C.M.S. - CALDERARO MEDICAL SERVICE
C.S.O
CENTERVUE
DALPASSO
DOC OFTA
FARMIGEA
GEUDER
LEICA MICROSYSTEMS
MEDIVIS
MEDONE SURGICAL
OCULUS
OERTLI
OMIKRON ITALIA
OPTIKON
RETINA IMPLANT
SANTEN
SPARK THERAPEUTICS
THEA
VITREQ
GENERAL INFORMATION
LANGUAGEEnglishistheofficiallanguageoftheCongress.SimultaneoustranslationswillbeprovidedintheAuditorium.
WEBSITETheofficialwebsiteiswww.floretina.it which will be constantly updated.On-line registration and hotel reservation are also available online.
CONGRESS VENUEPalazzo dei CongressiPiazzaAdua,1-50100Florence(Italy)Ph. +39 055 49721www.firenzefiera.it
REGISTRATIONPlease register only online on www.floretina.it
HOTEL RESERVATION Foranyinformationand/orreservationpleasecontacttheOfficialHousingBureauandTravelAgencyofthecongress:AIM Group International - Milan OfficeVia G. Ripamonti, 129 - 20141 Milan, ItalyPhone:+390256601308Fax:+390256609043E-mail:[email protected]
REGISTRATION FEESInterm Fee
March 1, 2017April 15, 2017
Onsite
Registration Fee € 400,00 € 450,00
Resident € 150,00
Nurse/Orthoptists € 120,00
AIM Group International - Florence OfficeViale G. Mazzini, 70 - 50132 Florence, ItalyPh.+39 055 233881 - Fax. +39 055 3906908 [email protected] - www.floretina.it
FLOREtina 2017ORGANIZING SECRETARIAT